Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the District Court for the District of Delaware has granted Parse's Motion for Summary Judgment of Invalidity for Scale Biosciences' 11,634
(Financial Post, 2025-10-09T12:06:36Z)